Page 9 - Pharmaceutical

Bajaj Healthcare forays into highly-regulated opiate processing business

Bajaj Healthcare said it has received two orders from the central government to produce active pharmaceutical ingredients (API) from poppy capsules and other derivatives on an annual basis

India's pharma exports touch Rs 1.8 trillion in FY22, flat over FY21

India ranks third worldwide for production in terms of volume and 14th by value, says commerce ministry.

Growth trajectory, margins anc client additions to sustain for Laurus Labs

Some of the growth is captured in the price rally, higher valuations

Dip in demand for Covid medicines takes a toll on drug sales in March

Covid related drugs contributed 40% of the pharma market last year

India hopes Hyderabad 'pharma city' will break China's grip on industry

India's ability to secure not just its own drug supply but that of Africa, the Americas and Europe is at stake

Lupin launches generic medication, to be manufactured in Nagpur, in US

Drug maker Lupin on Tuesday said it has launched Sevelamer Hydrochloride tablets (800 mg), used to treat hyperphosphatemia in patients with chronic kidney disease, in the US market

Biocon beefs up biosimilar portfolio with $3.3-bn Viatris deal, shares fall

The company in a statement said that its subsidiary Biocon Biologics has inked a pact to acquire Viatris Inc's biosimilars business for consideration of up to USD 3.335 billion

Top pharma firms to hike R&D spend next 5 yrs as mkt eyes $130 bn revenue

Industry captains feel pandemic has opened up opportunities for the sector in India to emerge as a second source of raw material and finished products, after China

Covid vaccine sales push Moderna to $12-bn profit in 2021

The vaccine maker's COVID-19 shots, which are now available in more than 70 countries, totalled USD 17.7 billion in sales last year, their first full year on the market

Purdue's Sacklers boost opioid settlement offer up to $6 billion

As part of the deal, Purdue will hand over nearly all of its assets to the states, cities and counties that are suing the drugmaker over its handling of the pain killer OxyContin

Reckitt quarterly sales beat estimates on boost from hygiene products

The company has benefitted during the pandemic from people buying more cleaning products, besides cold and flu remedies like Lemsip and Strepsils

Mankind Pharma acquires two derma and respiratory brands from Dr Reddy's

Mankind Pharma to take over manufacturing, marketing and distribution of both products in India; entire integration and transition of the brands likely to be completed by March

Hyderabad's Biophore to manufacture ingredients of Pfizer's Covid drug

Biophore India Pharmaceutical announced that it developed and started manufacturing the key intermediates of Nirmatrelvir, one of the active ingredients of Paxlovid, the latest anti-Covid therapy

Aurobindo Pharma gets warning letter from USFDA for API facility

Aurobindo Pharma on Friday said it has received a warning letter from the US health regulator for its Hyderabad-based Unit I, an API manufacturing facility.

Ipca Labs down 6% as stock turns ex-date for 1:1 split

The pharmaceutical company has fixed Tuesday, January 11, 2022, as the 'record date' for the members entitlement of sub-divided shares.

What ails Indian pharmaceutical space? Here's what CCI says

Cardiac medicines accounted for the highest volumes in 2020. Despite the burden of diabetes rising, its share in volumes was low; however, its share in total value was higher

Demerger to give a push to both pharma and financial services: Ajay Piramal

In a Q&A, the Chairman of Piramal Group talks about the prospects of both businesses, the rationale for the demerger and how supply side issues are impacting Indian companies

Drugs and Pharma sectors lead growth in India's exports from SEZs

Led by drugs and pharmaceuticals, India's exports from special economic Zones (SEZs) rose by 41.5 per cent on a year-on-year (YoY) basis to Rs 2.15 lakh crore in Q1FY22

Lupin, Glenmark shift focus to inhalation and nasal Covid-19 drugs

Lupin working on remdesivir powder inhaler; Glenmark to do trials on Nitric Oxide Nasal Spray

Alembic Pharma posts 45% dip in Q1 net at Rs 165 cr amid price erosion

Firm's consolidated revenues from operations also fell marginally to Rs 1,326 cr in Q1FY22, from Rs 1,341 crore a year ago